A major new study will soon provide genetic testing for spinal muscular atrophy (SMA) to all newborns in England. Former Little Mix singer Jesy Nelson, who has spent years advocating for this change, called the development a triumph for families facing the condition. Nelson, whose twin daughters were diagnosed with the disease, has openly shared the difficulties her children face, including the use of spinal jackets and foot splints.
SMA is a genetic disorder characterized by muscle weakness that inhibits movement and vital functions like breathing and swallowing. In severe cases, the illness can be fatal before a child reaches two years of age. While advanced gene therapies can address the underlying genetic issues, they are most effective when administered before symptoms develop, highlighting the urgent need for early detection.
Following similar screening programs already active in Scotland, the study in England is set to begin in October 2026, with a full national rollout expected by October 2027. Led by University of Oxford researchers, the initiative will screen hundreds of thousands of infants. This data will assist the UK National Screening Committee in determining whether such testing should be implemented permanently. Health Secretary James Murray praised the efforts of activists like Nelson, stating that no parent should witness their child lose physical capabilities when early intervention could have provided a different outcome.
